← Insider buys
EWTX

Edgewise Therapeutics, Inc. · Healthcare

Chief Scientific Officer Alan J Russell sold $2.1M of Edgewise Therapeutics, Inc.

Sold$2,120,101
$28.27Price
75,000Shares
−86%Stake

What EWTX did after the filing

Filed Sep 24Copier in Sep 25
The stock from Wed, Sep 25 open, $25.23
+45.1%
S&P 500, same days
+3.5%

Measured over 30 trading days, to the Nov 6 close.

Traded Fri, Sep 20. Filed Tue, Sep 24, 4:25 PM ET, after the close. Returns use the Sep 25 open and the Nov 6 close. Not investment advice.